IYH

iShares U.S. Healthcare ETF

Fundamental data last updated:September 20, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Asset Management

Exchange

AMEX

County of HQ

US

Next Earnings Date

Not Scheduled

Business Summary

The iShares U.S. Healthcare ETF seeks to track the investment results of an index composed of U.S. equities in the healthcare sector.

 


Analyze IYH on TradingView

VALUATION

P/E

N/A

Market Cap ($M USD)

$3.05B

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

N/A

PRICE TO BOOK

N/A

EV / EBITDA

N/A

5-Year Average P/E

Free Cash Flow Yield

N/A

DCF Value

N/A

Graham Number

N/A

Price to FCF

N/A

EV to FCF

N/A

Earnings Yield

N/A

FCF Yield

N/A

DIVIDEND

Yield

N/A

Annual Payout

N/A

Payout Ratio

N/A

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

N/A

Next Year EPS Growth Estimate

N/A

Next Year Revenue Growth Estimate

N/A

Return on Equity (ROE)

N/A

FREE CASH FLOW

Operating Margin

N/A

Debt-to-Equity

N/A

Piotroski F-Score

3

Altman Z-Score

40.92

Return on Invested Capital (ROIC)

N/A

Current Ratio

N/A

Quick Ratio

N/A

Net Debt to EBITDA

N/A

Interest Coverage

N/A

Gross Profit margin

N/A

FCF PER SHARE

N/A

REVENUE PER SHARE

N/A

Analyze IYH on TradingView

Gainseekers Quantitative Analysis

Summary

The Altman Z-score of 40.92 suggests that IYH is in a robust financial position, indicating minimal risk of bankruptcy. However, the absence of key valuation metrics like Forward P/E and Earnings Yield leaves a void in assessing its growth potential and market mispricing. The ETF’s distance from its 52-week high and low suggests a stable trading range, yet the lack of a DCF Value or Graham Number makes it challenging to determine if the market is mispricing it. Overall, while the financial health appears solid, the lack of detailed valuation metrics keeps us in the dark about its true value proposition.

AI Exposure / Tech Reliance

Operating within the asset management sector, IYH is well-positioned to leverage AI and tech advancements to optimize portfolio management and enhance client services. The industry's inherent adaptability to technological shifts provides a cushion against disruption. However, the ETF's specific strategies in this domain remain unspecified.

The Bull Case

For a value or GARP investor, IYH's compelling Altman Z-score stands out as a beacon of financial stability. Despite the absence of explicit ROIC or FCF Yield data, the ETF's resilience is underscored by its low beta of 0.59, suggesting reduced volatility. This stability, coupled with a Piotroski F-Score of 3, indicates moderate financial health, potentially appealing to those seeking a steady, albeit less aggressive, growth trajectory.

The Bear Case

The glaring absence of critical valuation metrics such as Price/Book, Price/Sales, and Forward P/E raises red flags for potential investors. Without these, assessing the ETF's market valuation becomes speculative at best. Additionally, trading below both its 50-Day and 200-Day SMAs suggests technical weakness, potentially deterring momentum-driven investors. The lack of earnings and cash flow data further clouds its financial transparency, posing a significant risk.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

N/A

Average Analyst Price Target

N/A

Institutional Ownership %

1-Year Beta

0.59

Insider Buying % (6 Mo)

Distance to 52-Week High

6.47%

Distance to 52-Week Low

15.08%

EARNINGS SURPRISE %

N/A

50-DAY SMA

$61.49

200-DAY SMA

$62.31

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.